Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod

Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an estimated 2.3 million people being affected globally, and is a major cause of permanent disability. About 90 % of the affected patients with MS have relapsing-remitting type. Fingolimod became...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Pushpinder, Lewis, Alana, Basit, Abdul, Cyr, Nikolas St, Muhammad, Zaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516047/
https://www.ncbi.nlm.nih.gov/pubmed/32995275
http://dx.doi.org/10.1016/j.idcr.2020.e00961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516047/
https://www.ncbi.nlm.nih.gov/pubmed/32995275
http://dx.doi.org/10.1016/j.idcr.2020.e00961

Ejemplares similares